Cagrilintide More Biotechnology In Chinese adults with overweight or obesity, once weekly #GLP glucagon agonist mazdutide, at a dose of 4 mg or 6 mg for 32 48 weeks, led to clinically relevant #weightloss in the Mazdutide and Tirzepatide: How These Dual Pathway Weight Loss Drugs Really Compare Peptides Unleashed Semaglutide vs Tirzepatide, Cagrilintide, and Retatrutide: Mechanisms & Research Insights GLP 1s effectiveness at blood pressure control on par with traditional anti hypertensives, tracks well with % weight loss. In someone with hypertension due to their underlying obesity, why not Michael Weintraub, MD Advances in obesity pharmacotherapy; learning from metabolic surgery and beyond ScienceDirect